PoreWise
✓ Human-reviewed

Ingredient

Niacinamide

Public database

NIACINAMIDE

Niacinamide is vitamin B3. Used for barrier support and to reduce the look of uneven tone; evidence is stronger for barrier effects than for brightening. The strongest evidence comes from a 2008 human trial: In a randomized, placebo-controlled split-face study of 30 healthy Japanese women, a cosmetic containing 4% niacinamide reduced the skin-surface average roughness (Ra) value significantly more than the niacinamide-free control site after 8 weeks (P<0.05). 2008 · 30 people · healthy Japanese women with wrinkles in the eye areas · PMID 19017042 · Measured at the eye area on a photoaged/wrinkle cohort; the endpoint is surface roughness. 23 products contain Niacinamide; the highest it appears is number 2 of 27.

INCI name:
NIACINAMIDE
CAS number:
98-92-0
Source:
PubChem

Products with this ingredient

Niacinamide appears on 23 product ingredient lists, most often around number 6; its highest position is number 2 of 27.

Studies and results

  1. 1 Skin effect
    Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide

    In a randomized, placebo-controlled split-face study of 30 healthy Japanese women, a cosmetic containing 4% niacinamide reduced the skin-surface average roughness (Ra) value significantly more than the niacinamide-free control site after 8 weeks (P<0.05).

    Human trial · 2008 · 30 people · healthy Japanese women with wrinkles in the eye areas · Skin-surface roughness measured by replica profilometry (Ra). · Measured at the eye area on a photoaged/wrinkle cohort; the endpoint is surface roughness.

    PMID 19017042

  2. 2 Skin effect
    An Investigator-Blinded, Randomized Trial of a Broad-Spectrum Sunscreen Containing Sclareolide and Niacinamide for the Prevention of Post-inflammatory Hyperpigmentation in Skin of Color

    In 20 people with Fitzpatrick skin types IV-V, a broad-spectrum sunscreen containing sclareolide and niacinamide significantly prevented experimentally induced post-inflammatory hyperpigmentation: in stripped, exposed zones the protected skin improved by +5.96 ITA degrees versus -9.88 in unprotected skin (net protection about 16 ITA degrees, p < 0.001).

    Human trial · 2026 · 20 people · participants with Fitzpatrick skin types IV-V · People with darker skin phototypes (IV-V) prone to post-inflammatory hyperpigmentation, applying the sunscreen daily for 20 days under UV and visible-light exposure. · Small sample (20), within-subject controlled model of experimentally induced pigmentation; the abstract calls for comparative studies with and; industry involvement.

    PMID 41240206

  3. 3 Skin effect
    Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies

    In 72 women with visible signs of ageing, a niacinamide-containing biomimetic lamellar cream significantly improved the Cutometer R5 elasticity parameter, wrinkle score, TEWL and corneometer values over 4 weeks compared against the untreated side.

    Human trial · 2019 · 72 people · women with visible signs of ageing (Study 2) · Women with visible signs of ageing, applying the cream twice daily for 4 weeks. · Grading of high-resolution images failed to detect improvements in skin texture; proof-of-concept studies.

    PMID 30414275

  4. 4 Skin effect
    A Novel Dermocosmetic Routine Containing Vitamin B3 and 2-Mercaptonicotinyl Glycine Significantly Improves Melasma After 3 Months of Daily Use

    In 91 women with melasma, a skincare routine containing vitamin B3 (niacinamide) and 2-mercaptonicotinyl glycine significantly reduced MASI after 3 months, with roughly 38-41% reduction by 6 months.

    Human trial · 2025 · 91 people · women with melasma · Women aged about 44 with melasma, phototypes III-IV, using the routine twice daily with daily SPF50+ sunscreen. · A clinically relevant difference favoured Kligman's triple combination in the first 3 months; industry-funded; skin radiance and fine wrinkles also improved.

    PMID 41036635

  5. 5 Skin effect
    The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial

    In a randomized, double-blind, placebo-controlled split-face trial of 52 Taiwanese subjects, 4% niacinamide alone significantly reduced instrument-measured pore counts at week 8, and 4% niacinamide with 0.03% kinetin produced persistent significant reductions in pore, spot, wrinkle and evenness counts at weeks 8 and 12.

    Human trial · 2007 · 52 people · Taiwanese subjects · Instrument-measured facial pore counts over 8-12 weeks. · The niacinamide-group showed significant pore reduction at week 8; 'pore counts' is an instrument parameter.

    PMID 18047609

  6. 6 Skin effect
    The effect of 2% niacinamide on facial sebum production

    In a double-blind, placebo-controlled trial of 100 Japanese subjects, a 2% niacinamide moisturiser significantly lowered sebum excretion rate after 2 and 4 weeks; in a separate 30-person Caucasian split-face study it significantly reduced casual sebum level after 6 weeks.

    Human trial · 2006 · 100 people · Japanese subjects plus 30 Caucasian subjects · Adults with facial sebum concerns applying a 2% niacinamide moisturiser for 2 to 6 weeks; measured with sebumeter-based sebum excretion rate and casual sebum level. · The effect differs by measured endpoint and population.

    PMID 16766489

  7. 7 Skin effect
    Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial

    In 40 people with mild-to-moderate acne all using topical benzoyl peroxide plus adapalene, a moisturiser with ceramides and niacinamide significantly improved non-inflammatory, inflammatory and total acne lesions on that side of the face versus a hydrophilic cream after 8 weeks, and decreased cutaneous irritation.

    Human trial · 2024 · 40 people · patients with mild-to-moderate acne, all on topical anti-acne treatment · People on topical anti-acne medication who add a moisturiser alongside treatment, in a split-face, double-blind, randomized design for 8 weeks. · All participants used prescription/OTC anti-acne drugs (5% benzoyl peroxide + 0.1% adapalene). TEWL, hydration, sebum, pH and other biophysical measures stayed close between the two creams. This is adjunctive care.

    PMID 38299457

  8. 8 Skin effect
    Superior even skin tone and anti-ageing benefit of a combination of 4-hexylresorcinol and niacinamide

    In a 12-week randomized, double-blind half-face study, a combination of 4-hexylresorcinol and niacinamide improved hyperpigmentation spots (L*), the appearance of fine lines and wrinkles, and skin firmness significantly more than niacinamide alone.

    Human trial · 2022 · Chinese adults in a randomized, double-blind half-face clinical study · Chinese adults using the combination cream twice daily for 12 weeks in a split-face design. · Industry-funded (Unilever R&D); part of the evidence comes from in-vitro melanocyte and 3D skin models.

    PMID 34958693

  9. 9 Skin effect
    Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea

    A facial moisturiser containing niacinamide improved stratum corneum barrier function and skin hydration, measured instrumentally, in people with rosacea over four weeks of twice-daily use.

    Human trial · 2005 · 50 people · Adults with rosacea · A leave-on facial moisturiser, applied twice daily for four weeks, in adults with rosacea. · The tested article was a finished moisturiser. Fifty participants, one centre, four weeks. The study measured barrier function and hydration.

    PMID 16209160

  10. 10 Skin effect
    A Randomized, Controlled Clinical Trial of a Dermocosmetic Containing Vichy Volcanic Mineralizing Water and Probiotic Fractions in Subjects with Rosacea Associated with Erythema and Sensitive Skin and Wearing Protective Masks

    In a randomized split-face controlled trial in people with rosacea-associated erythema and sensitive skin, a dermocosmetic containing mineralizing water, probiotic fractions, hyaluronic acid and niacinamide significantly improved erythema at day 15 (p<0.01) and day 30 (p<0.001), with skin erythema, tightness, dryness, hydration and TEWL improving versus the untreated side (p<=0.05).

    Human trial · 2023 · People with rosacea-associated erythema and sensitive skin wearing protective masks · Facial erythema, tightness, dryness, hydration and TEWL over 30 days. · The comparator is usual skin care / an untreated half-face.

    PMID 36660190

  11. 11 Skin effect
    Topical nicotinamide for seborrheic dermatitis: an open randomized study

    In an open randomized, vehicle-controlled trial of 48 people with mild-to-moderate facial seborrheic dermatitis, 4% nicotinamide cream once daily for 12 weeks reduced the combined erythema/scaling/infiltration score by 75% from baseline versus 35% with the vehicle (p<0.05).

    Human trial · 2014 · 48 people · people (36 men, 12 women) aged 20-50 with mild-to-moderate facial seborrheic dermatitis · Combined clinical score of erythema, scaling and infiltration over 12 weeks. · Open-label.

    PMID 23763270

  12. 12 Skin effect
    Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation

    In 30 women with melasma or post-inflammatory hyperpigmentation, a serum combining lotus sprout extract, tranexamic acid and niacinamide reduced skin tone unevenness by 38% and 33% respectively over 16 weeks (P < 0.008).

    Human trial · 2026 · 30 people · women (15 melasma, 15 PIH), 70% Fitzpatrick IV-VI · Women with melasma or PIH, 70% with Fitzpatrick skin types IV-VI, applying the serum twice daily for 16 weeks. · 30 participants; "skin tone unevenness" is a sponsor-defined endpoint.

    PMID 42406361

Skin concerns this ingredient has been studied for

The people in each study had that concern.

Common questions

What does Niacinamide do in skincare?
Niacinamide is vitamin B3. Used for barrier support and to reduce the look of uneven tone; evidence is stronger for barrier effects than for brightening.
Where does Niacinamide sit in these formulas?
Niacinamide appears in 23 products; highest on the list is number 2 of 27, in 10% Niacinamide Booster.
Which products contain Niacinamide?
Products that contain Niacinamide: 10% Niacinamide Booster, Eye Repair Cream, Niacinamide 10% + Zinc 1%, Positively Radiant Vitamin C Serum, Mela B3 Serum, Niacinamide 10% + TXA 4% Serum. Plus 17 more.
How strong is the evidence behind Niacinamide?
12 findings on Niacinamide; the strongest is a 2008 human trial of 30 healthy Japanese women with wrinkles in the eye areas.
What did the study on Niacinamide measure?
2008 · 30 people · healthy Japanese women with wrinkles in the eye areas · PMID 19017042 · Measured at the eye area on a photoaged/wrinkle cohort; the endpoint is surface roughness.

Related ingredients